Puma Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Name: Puma Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Puma Biotechnology Inc
Rating: 3.3606805
Author: Trendlyne DVM scores

Strong Performer, Under Radar

about

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

3.39 -0.13 (-3.69%)

52.70% Gain from 52W Low

300.7K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

High Financial Strength

72.2 / 100

Affordable Valuation

67.5 / 100

Technically Neutral

56.9 / 100

Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM

1Yr Price target downside is -12%

2 analysts

Puma Biotechnology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Puma Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

52.70% Gain from 52W Low

SWOT Analysis

Puma Biotechnology Inc Live Price Chart